TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action

Authors

Dennis T. Villareal, Washington University School of Medicine in St. Louis
Heather Robertson, Washington University School of Medicine in St. Louis
Graeme I. Bell, University of Chicago
Bruce W. Patterson, Washington University School of Medicine in St. Louis
Hung Tran, Washington University School of Medicine in St. Louis
Burton Wice, Washington University School of Medicine in St. Louis
Kenneth S. Polonsky, Washington University School of Medicine in St. Louis

Areas of Expertise

Dennis T. Villareal, 6680 Geriatrics; Kenneth S. Polonsky, 6630 Diabetes

Journal

Diabetes

Volume

59

Issue

2

Document Type

Article

Pages

479-485

Publication Date

2010

Recommended Citation

Villareal, Dennis T.; Robertson, Heather; Bell, Graeme I.; Patterson, Bruce W.; Tran, Hung; Wice, Burton; and Polonsky, Kenneth S., "TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action". Diabetes, 479-485. 2010. Paper 42.
https://digitalcommons.wustl.edu/icts_facpubs/42